FIELD: medicine.
SUBSTANCE: there is offered application of macrolide antibiotic tylvalosin (the very same 3-acetate 4B-(3-methylbutanoate tylosin) as an antiviral agent and a related method of treating a viral infection. Tylvalosin is especially effective in treating PRRSV as inhibits its distribution immediately after infection.
EFFECT: tylvalosin induced inhibition of PRRSV virus and influenza type A virus replication.
27 cl, 19 dwg, 5 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABILISED VACCINE COMPOSITION FOR STIMULATION OF IMMUNE RESPONSE AND METHOD FOR ITS OBTAINING | 2003 |
|
RU2339400C2 |
| MYCOPLASMA AND PRRSV VACCINE | 2007 |
|
RU2408386C2 |
| IMMUNOGENIC COMPOSITIONS COMPRISING SILICIFIED VIRUS AND METHODS OF USE | 2014 |
|
RU2676083C2 |
| METHOD OF MICROORGANISM DETECTION IN BIOLOGICAL SAMPLE | 2007 |
|
RU2435865C2 |
| RELIEVING CONCURRENT INFECTIONS IN PIGS USING PCV2 ANTIGEN | 2008 |
|
RU2491092C2 |
| LUNG CELLS OF COTTON RATS FOR CULTIVATION OF VIRUSES | 2003 |
|
RU2376370C2 |
| METHODS AND COMPOSITIONS FOR INHIBITING POLYMERASE | 2011 |
|
RU2718690C2 |
| METHODS AND COMPOSITIONS FOR INHIBITING POLYMERASE | 2011 |
|
RU2599013C2 |
| USE OF COMPOSITION IN PREVENTION AND/OR TREATMENT OF PATHOGENIC INFECTIONS IN ANIMALS | 2021 |
|
RU2809765C1 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
